SX-682

A Phase 1, Open-Label, Dose-Escalation With Expansion Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Near Add Your Location

Sorting 7 by

Center of Excellence

Sidney Kimmel Comprehensive Cancer Center
Johns Hopkins Medicine
Baltimore, MD
  • Accepting patients

Center of Excellence

Moffitt Cancer Center
Magnolia Campus
Tampa, FL
  • Accepting patients

Center of Excellence

Mayo Clinic (Jacksonville)
Jacksonville, FL
  • Accepting patients
  • Show Principal Investigator

Center of Excellence

Sylvester Comprehensive Cancer Center (Main)
University of Miami Health System
Miami, FL
  • Accepting patients

Center of Excellence

Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.